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Although  foxes  are the main  reservoir  of  Echinococcus  multilocularis,  it is recognized  that
dogs and  cats  also  may  become  infected.  In cats  the  infection  and  egg  production  rates  are
usually  low.  Nevertheless,  cats are  a potential  source  of transmission  of  E.  multilocularis.
Due  to the high  human  medical  signiﬁcance  of  E. multilocularis  infection,  it is  important  in
endemic  areas  that owned  cats  are dewormed  regularly.  This  paper  presents  the efﬁcacy
results  of a new  topical  formulation,  Broadline® (Merial)  tested  against  E. multilocularis
infection  in  cats.  Two  blinded  laboratory  studies  were  conducted  to evaluate  this  novel
topical  combination  of  ﬁpronil,  (S)-methoprene,  eprinomectin,  and  praziquantel  against
E. multilocularis.  In each  study,  purpose-bred  cats  were  assigned  randomly  to two  treat-
ment groups  of 10 cats  each:  one  untreated  control  group  and  one  group  treated  at  the
minimum  therapeutic  dose  of  0.12  mL/kg  bodyweight  to  deliver  10 mg  ﬁpronil,  12  mg (S)-
methoprene,  0.5 mg  eprinomectin  and  10 mg  praziquantel/kg  bodyweight.  The  cats  were
inoculated  orally  with  E.  multilocularis  protoscolices,  22 or 23 days  before  treatment.  Based
on necropsy  and  intestinal  worm  count,  8 or  11  days  after  treatment,  the  two  studies
conﬁrmed  100%  efﬁcacy  of  Broadline® against  adult  E.  multilocularis.
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1. Introduction
Echinococcus multilocularis is distributed widely in the
Northern Hemisphere and is endemic in central Europe and
in various regions of North America and Asia (Gottstein
et al., 1996; Romig, 2003; Romig et al., 2005; Davidson et al.,
2012). The deﬁnitive host of E. multilocularis is the fox (red
fox and arctic fox), but other carnivores, such as wild canids
(e.g. wolves, coyotes), wild felids, raccoons, or domestic
dogs and cats, may  serve as hosts. Intermediate hosts are
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licenses/by-nc-nd/3.0/).lished  by  Elsevier  B.V.  This  is an  open  access  article  under  the  CC
D  license  (http://creativecommons.org/licenses/by-nc-nd/3.0/).
small rodents, mainly Microtidae (e.g. voles, muskrats, lem-
mings, hamsters, gerbils and related species) (Eckert and
Deplazes, 2004; Burlet et al., 2011). The prevalence of the
parasite is considered to be increasing and it is spreading
to new countries through the movement of wildlife. The
parasite also has spread from rural to urban areas, because
of the increase in urban fox populations (Romig, 2003;
Deplazes et al., 2004; Jenkins et al., 2005; Fischer et al.,
2005; Deplazes, 2006; Takumi et al., 2008; Dakkak, 2010;
Siko et al., 2011; Davidson et al., 2012; Takumi et al., 2012).
Human exposure is becoming more common in endemic
area and may  be exacerbated by contact with infested
domesticated carnivores (Dyachenko et al., 2008). E. multi-
locularis has a high human medical signiﬁcance by causing
ss article under the CC BY-NC-ND license (http://creativecommons.org/
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Table 1
Characteristics of experimental animals.
Study Sexa Ageb
(months)
Pre-treatmentc
body weight (kg)
Study 1 10M, 10 F 7 2.4–5.8
Study 2 10M, 10 F 7–11 2.3–6.1E. Tielemans et al. / Veterin
lveolar echinococcosis, which can be fatal (Vuitton et al.,
003; Deplazes and Eckert, 2001).
Transmission of E. multilocularis usually occurs via a syl-
atic cycle, with the possibility of infection of domestic
ogs and cats via infected small mammals. The deﬁni-
ive host harbours the adult cestode, and the infestation
ypically is asymptomatic. Eggs are passed in the faeces
f the deﬁnitive host and contaminate the environment.
ggs have a patency of 2–4 months and may  remain infec-
ive in the environment for many months or years, in cool
nd damp conditions. Eggs are ingested by an intermediate
ost and develop into alveolar metacestode cysts. Metaces-
ode cysts contain numerous vesicles, each containing high
umbers of protoscolices, the infective form. In the inter-
ediate host, the metacestode larva is characterized by
n exogenous tumour-like tissue proliferation, which pro-
ressively inﬁltrates the infected organ and may  lead to
evere disease and death. Intermediate hosts are preyed
pon by carnivores. When ingested by the deﬁnitive host,
rotoscolices evolve into adult E. multilocularis in the small
ntestine, and egg production can begin as early as 25 days
fter infestation. Eggs also may  be ingested by aberrant
osts, such as pigs, horses, monkeys and humans. Such
ngestion may  cause alveolar echinococcosis, one of the
ost lethal helminthic infection in humans (Deplazes and
ckert, 2001; Bowman et al., 2003; Eckert and Deplazes,
004; Davidson et al., 2012).
In comparison to dogs and wild canids, cats shed fewer
. multilocularis eggs, for a shorter duration. Therefore, cats
ppear to have a lesser role in the maintenance of E. multi-
ocularis in endemic area, and infestations in cats may  be of
ore limited public health signiﬁcance (Thompson et al.,
003, 2006; Kapel et al., 2006; Learmount et al., 2012).
evertheless, cats are regarded as a potential source of
ontamination for intermediate hosts including humans
Thompson et al., 2003; Dyachenko et al., 2008) and should
e treated on a regular basis when they have regular out-
oor access in endemic areas. Praziquantel, administered
y topical and oral routes, has long been established as
n efﬁcient treatment against E. multilocularis infestations
n cats and dogs (Jenkins and Romig, 2000; Charles et al.,
005; Schroeder et al., 2009; Knaus et al., 2014; Rehbein
t al., 2014). Merial has developed Broadline®,1 a topical
ndo- and ectoparasiticide drug for cats combining ﬁpronil
.3% (w/v), (S)-methoprene 10% (w/v), eprinomectin 0.4%
w/v), and praziquantel 8.3% (w/v). The present investiga-
ions were carried out to evaluate the efﬁcacy of a single
opical treatment with that novel formulation against E.
ultilocularis infestations in cats.
. Materials and methods
The two study designs used were in accordance with
he International Cooperation on Harmonisation of Techni-
al Requirements for Registration of Veterinary Medicinal
roducts VICH GL7, “Efﬁcacy of Anthelmintics: General
equirements” (Vercruysse et al., 2001) and VICH GL20
1 Broadline® is a trademark of Merial; all other marks are the property
f  their respective owners.a M,  male; F, female.
b Age on the day of treatment (=Day 0).
c Day –2, prior to treatment.
“Efﬁcacy of Anthelmintics: Speciﬁc Recommendations
for Felines” (Vercruysse et al., 2002), and the “World
Association for the Advancement of Veterinary Parasito-
logy (WAAVP) guidelines for evaluating the efﬁcacy of
anthelmintics for dogs and cats” (Jacobs et al., 1994); and
the studies were conducted in compliance to VICH GL9
entitled Good Clinical Practice. Animals were managed simi-
larly and with due regard for their well-being in compliance
with the local Ethics Committee approvals and other local
applicable regulations and requirements.
The studies described here were blinded, laboratory-
based, single centre, clinical efﬁcacy studies, with an
untreated control group and used a randomized block
design based on bodyweight. Healthy laboratory purpose-
bred European Short Hair cats were included (see Table 1).
None of the cats had been treated with an endoparasiticide
within 3 months of acclimatization start.
In the two  studies, cats were housed individually in a
controlled environment with an air conditioning system.
They were identiﬁed individually with microchips. They
were observed at least once daily for general health during
the entire in-life phase and had a veterinary examination
for suitability before E. multilocularis inoculation. The cats
were also observed hourly four times after application of
the treatment.
After acclimatization of at least 8 days to the study
environment and conditions, cats were sedated and orally
inoculated with protoscolices. Cats were fasted overnight
before the inoculation. A viability assessment, based on
motility of protoscolices seen under the microscope, was
performed shortly before the inoculation. For each inocu-
lation, the container of E. multilocularis was shaken lightly
to ensure uniform suspension and the volume loaded in
a disposable syringe. The syringe was connected to an
appropriate-sized ﬂexible tube, the tube was inserted into
the oesophagus, and the inoculum expelled. The tube was
ﬂushed with ∼2 mL  of saline before removal. Each cat was
inoculated with approximately 30,000 (Study 1) and 38,000
protoscolices (Study 2) at Day −23 (Study 1) or Day −22
(Study 2). Protoscolices of E. multilocularis for both studies
originated from common voles infected with recent ﬁeld
isolates (<10 years) that were obtained from red foxes from
central Europe (Germany).
Cats were ranked by body weights and then assigned
to 10 blocks of 2 cats each. Within blocks cats were allo-
cated randomly to the untreated control group or the
treated group. All cats were weighed on study Day −2
for treatment dose calculation. Treatments were applied
on study Day 0. The test product was  applied at the
minimum therapeutic dose of 0.12 mL/kg body weight
directly on the skin in the midline of the neck between
ary Para28 E. Tielemans et al. / Veterin
the base of the skull and the shoulder blades in a sin-
gle spot. The dosage was 10 mg/kg ﬁpronil, 12 mg/kg
(S)-methoprene, 0.5 mg/kg eprinomectin, and 10 mg/kg
praziquantel. Timing of the interval between inoculation
with E. multilocularis and treatment was designed so that
the parasites were expected to be adults on study Day 0. All
cats were observed hourly four times after treatment. On
study Day 8 (Study 1) or study Day 11 (Study 2), cats were
humanely euthanized, and the intestines were collected for
parasite identiﬁcation and count to assess treatment effec-
tiveness. Intestines were ligated and collected from pyloric
to rectal end. They were packaged individually and stored
frozen at −70 ◦C for at least 4 weeks before parasite counts.
For the counts, thawed intestines were opened completely
with a pair of scissors, and the entire contents (including
the mucosa) were screened through a 150 m mesh size
sieve. The remaining material on the sieve was retained and
preserved. A 20% aliquot of the preserved material from
each complete sample was examined for E. multilocularis
scolices using a dissection microscope. For samples con-
taining <10 scolices in the 20% aliquot, the remaining 80%
were examined for E. multilocularis to provide a total count.
For samples containing ≥10 scolices, total counts per ani-
mal  were calculated by multiplying the number of scolices
actually counted by the aliquot factor of 5.
Counts of the parasites were transformed to the nat-
ural logarithm of (count + 1) for calculation of geometric
means for each treatment group. Efﬁcacy was determined
for E. multilocularis by calculating the percent efﬁcacy as
100[(C − T)/C], where C is the geometric mean count among
untreated controls and T is the geometric mean count
among the treated animals. To compare the geometric
means of the two groups, the mean of the log-counts of the
treated group was compared to the mean of the log-counts
of the untreated control group using an F-test adjusted for
the allocation blocks used to randomize the animals to the
treatment groups. The mixed procedure in SAS® version
9.1.3 was used for the analysis, with the treatment groups
listed as a ﬁxed effect and the allocation blocks listed as
a random effect. All testing used a two-sided signiﬁcance
level  ˛ = 0.05.
3. ResultsNo adverse events or other health problems were
observed after treatment application and throughout the
studies, indicating that treatment with topical formulation
Table 2
Parasite counts and therapeutic efﬁcacy of Broadline® spot-on against experimen
Echinococcus multilocularis counts 
Untreated (control) Treated
NI/NGd GMe (range) NI/NG 
Study 1 9/10 24.0 (0–230) 0/10 
Study  2 8/10 8.33 (0–5445) 0/10 
a Broadline® spot on = ﬁpronil (8.3%, w/v), (S)-methoprene (10%, w/v), eprinome
b Efﬁcacy = 100 [(geometric mean untreated (control) group − geometric mean
c Two-sided p-value comparing the worm burden of the Topical FMEP group w
d NI/NG, number of cats infected/number of cats in group.
e Geometric mean count (based on transformation to ln[count + 1]).sitology 202 (2014) 26–29
of ﬁpronil, (S)-methoprene, eprinomectin and praziquantel
was  well accepted.
In Study 1, 2–230 E. multilocularis scolices were recov-
ered from 9 untreated control cats, and the geometric mean
number for the group was 24.0. In Study 2, 18–5445 E. mul-
tilocularis scolices were recovered from 8 untreated control
cats, and the geometric mean number for the group was
100.8. In both studies, no E. multilocularis scolices were
recovered from any of the treated cats. In both studies,
adequacy of infestation per VICH Guidelines 7 and 20 was
achieved, and efﬁcacy was  100% with a signiﬁcant differ-
ence (P < 0.001) from the control group (Table 2).
The establishment rate (mean number of E. multilocu-
laris scolices found at necropsy/number of protoscolices
inoculated in the untreated control groups) of the two E.
multilocularis isolates were 0.08% for Study 1 and 0.27% for
Study 2.
4. Discussion
The life cycle of E. multilocularis is predominantly syl-
vatic with foxes and raccoon dogs as deﬁnitive hosts,
nevertheless domestic dogs and to a lesser extent cats may
take this role. It has been suggested that the signiﬁcance
of cats in its epidemiology is lower than that of foxes or
dogs, when comparing the reproductive potential of the
parasite in these hosts (Kapel et al., 2006; Thompson et al.,
2006). Establishment rates of induced infections in these
studies (0.08% or 0.27%) are in line with rates of other stud-
ies (Thompson et al., 2006) and complement the known
low susceptibility of cats as deﬁnitive hosts. However,
due to their hunting behaviour, cats may  pray on rodents
more often than dogs, so that cats with regular outdoor
access may  be more frequently exposed to protoscol-
ices of E. multilocularis than expected. Molecular-biological
examination of faecal samples in a cross-sectional survey
identiﬁed E. multilocularis DNA in 68% of taeniid-positive
samples from cats in Europe (Dyachenko et al., 2008).
Even though the risk of zoonotic transmission from
cats is still poorly understood, in order to prevent any
risk of cats acting as a source of eggs, they should be
treated on a regular basis when they have outdoors access
and hunting activities in endemic areas. Praziquantel is an
established compound with well-proven efﬁcacy against
cestodes, including E. multilocularis,  and has an excellent
safety proﬁle in several animal species and when given
by different routes of administration (Jenkins and Romig,
tally induced Echinococcus multilocularis in cats.
Efﬁcacy (%)b P-valuec
a
GM (range)
0.0 (0) 100 <0.001
0.0 (0) 100 <0.001
ctin (0.4%, w/v), and praziquantel (8.3%, w/v); at 0.12 mL/kg body weight.
 Topical FMEP group)/geometric mean untreated (control) group].
ith untreated (control) group.
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000; Charles et al., 2005; Schroeder et al., 2009). Results
f these two studies using induced infections of E. mul-
ilocularis have demonstrated a high level of efﬁcacy of
he novel topical combination of ﬁpronil, (S)-methoprene,
prinomectin and praziquantel. These data complement
he results of a study which was conducted to evaluate the
fﬁcacy of Broadline® against helminth infections under
eld conditions (Rehbein et al., 2014). The novel topical
ombination formulation can provide an efﬁcacious and
onvenient solution for the treatment of cats for infections
ith E. multilocularis.
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